IFNG and Schwartz-Jampel syndrome: In our study, all the SJS and TEN patients exhibited circulating IFN-γ-producing T cells upon ex vivo restimulation with the drugs, which, in line with previous studies [20], [22], suggests that in vitro IFN-γ release tests could be useful for identifying the drugs associated with SJS and TEN.